Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Mar 27, 2023; 15(3): 420-429
Published online Mar 27, 2023. doi: 10.4240/wjgs.v15.i3.420
Published online Mar 27, 2023. doi: 10.4240/wjgs.v15.i3.420
Table 4 Data comparison between patients with mild/moderate or severe inflammatory bowel disease
| Variables | Mild/moderate (n = 31) | Severe (n = 12) | Statistical value (t/χ2) | P value |
| Systolic pressure (mmHg), mean ± SD | 107.33 ± 11.698 | 94.45 ± 7.71 | 3.482 (t) | 0.0011 |
| Variety of disease | 12.542 (Adjusted) | 0.0001 | ||
| Crohn disease | 25 | 2 | ||
| Ulcerative colitis | 6 | 10 | ||
| Pre-op corticosteroids | 6.408 | 0.0111 | ||
| No | 21 | 3 | ||
| Yes | 10 | 9 | ||
| Latent Epstein-Barr virus infection | 8.911 (Adjusted) | 0.0031 | ||
| Negative | 28 | 5 | ||
| Positive | 3 | 7 |
- Citation: Wei HT, Xue XW, Ling Q, Wang PY, Zhou WX. Positive correlation between latent Epstein-Barr virus infection and severity of illness in inflammatory bowel disease patients. World J Gastrointest Surg 2023; 15(3): 420-429
- URL: https://www.wjgnet.com/1948-9366/full/v15/i3/420.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i3.420